Lancée au printemps 2020, l’étude française CORONADO avait pour objectif de décrire les caractéristiques phénotypiques des patients diabétiques hospitalisés pour la prise en charge d’une infection COVID-19. Cette étude de recherche clinique coordonnée par l’institut du thorax étant aujourd’hui terminée, nous vous proposons de consulter les 20 publications scientifiques issues de ces travaux :
19/10/2022
20/08/2022
15/06/2022
Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative, Diabetes and Metabolism
16/02/2022
COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study, Diabetes and Metabolism
23/10/2021
17/10/2021
Influenza vaccination and prognosis for COVID-19 in hospitalized patients with diabetes: Results from the CORONADO study, Diabetes, Obesity and Metabolism
29/09/2021
29/06/2021
Glucose-lowering treatments and COVID-19 mortality in T2DM, Nature reviews endocrinology
29/06/2021
Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study, European Journal of
Endocrinology
17/02/2021
09/02/2021
Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: results from the CORONADO study, Diabetes Research and Clinical Practice
02/02/2021
07/01/2021
Diabète et COVID-19 : les leçons de CORONADO, Médecine des Maladies Métaboliques
14/12/2020
20/11/2020
19/10/2020
14/10/2020
Relationship between obesity and severe COVID‐19 outcomes in patients with type 2 diabetes: Results from the CORONADO study, Diabetes, Obesity and Metabolism
26/08/2020
20/08/2020